Cambridge Cons debuts sec-gen DPI generic spec

Cambridge Consultants has released its latest dry-powder inhaler generic specification to address recent regulatory requirements and  technological developments, helping speed up the development process and  time to market for inhalation devices. The specification describes the  requirements that guide the development of inhalers - including  marketing needs, user experiences, up-to-date regulatory information,  technological considerations such as the use of electronics, and safety  and performance needs - providing a fast-track to device development. In  addition, the specification conforms to the new ISO20072 standard.

Since the launch of the first version by Cambridge Consultants in 2002,  the DPI generic specification has been shared with more than a hundred  organizations interested in developing better inhalers. Based on  experience gained from Cambridge Consultants' ongoing projects in the  sector, the specification has been updated to incorporate emerging  technologies within the inhaler market.

The legislative requirements that govern the development of dry-powder  inhalers remain consistent in all cases, meaning that this generic  specification can be customised for any DPI development, allowing for  the rapid development of new devices, the firm says.